@article{0337f2c3d93346788ccb6323a76ab1a0,
title = "No evidence for a genetic modifier for renal cell cancer risk in HLRCC syndrome",
keywords = "Fumarate hydratase, Genetic testing, HLRCC, Modifier, Renal cell cancer, FUMARATE HYDRATASE MUTATIONS, HEREDITARY LEIOMYOMATOSIS, UTERINE LEIOMYOMATOSIS, CUTANEOUS LEIOMYOMATOSIS, MISSENSE MUTATIONS, CLINICAL-FEATURES, TUMOR SYNDROME, FH, PARAGANGLIOMA, DEFICIENCY",
author = "Pia Vahteristo and Koski, {Taru A.} and Laura Naatsaari and Maija Kiuru and Auli Karhu and Riitta Herva and Satu-Leena Sallinen and Outi Vierimaa and Erik Bjorck and Stephane Richard and Betty Gardie and Didier Bessis and {Van Glabeke}, Emmanuel and Ignacio Blanco and Richard Houlston and Leigha Senter and Marja Hietala and Kristiina Aittomaki and Aaltonen, {Lauri A.} and Virpi Launonen and Rainer Lehtonen",
year = "2010",
doi = "10.1007/s10689-009-9312-2",
language = "English",
volume = "9",
pages = "245--251",
journal = "Familial Cancer",
issn = "1389-9600",
publisher = "Springer",
}